Wellgistics Health to DataMeds AI
Analysis based on 6 articles · First reported Jun 26, 2026 · Last updated Jun 26, 2026
The proposed name change of Wellgistics to DataMeds AI, Inc. and the rebranding of its division to Corexa Health signal a strategic shift towards a vertically integrated healthcare ecosystem. This could positively impact investor confidence in Wellgistics's future growth prospects, especially given the focus on AI, blockchain, and patient data ownership, potentially leading to increased stock valuation if the strategy proves successful.
Wellgistics, Inc. announced its management and Board of Directors have selected DataMeds AI, Inc. as its new corporate name, pending shareholder approval. The company is also rebranding its Pharmacy and Pharmacy Services division to Corexa Health. This move reflects a strategic shift towards a vertically-aligned healthcare ecosystem, integrating telemedicine, online pharmacy, lab tests, and wearables with AI and blockchain technology. The new entity, DataMeds AI, aims to empower patients to own and monetize their health data through the Health Lives Here app, expanding its EinsteinRx AI capabilities. This change is concurrent with a proposed transaction involving Datavault AI, Scilex Holding Company, Priority Technology Holdings, and HealthBridge Advisors, anticipated to close in Q3 2026. The company also provided an update on its outstanding common shares and warrants.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard